Researchers at the National Cancer Institute estimate that roughly 14.5 million U.S. citizens are living with cancer, and that number is expected to increase significantly by the year 2024. Thanks to the recent advancements in medical technology, companies have more opportunity to find ways to merge cancer care with technology. Such is the case for Tempus, a leader in data-driven cancer treatment.
When Eric Lefkofsky, co-founder of Tempus, had an up close and personal experience with the difficult condition after his wife was diagnosed with breast cancer, he had doubt about the knowledge of data-driven treatment options. While doctors seemed to collect a significant amount of data on his wife, he wondered how much of that data had been used to develop a personalized plan of action for her. He founded Tempus with a mission to bridge the gap between data and cancer care. The patient data that is collected and stored in Tempus will help future patients, as physicians gather crucial information to advance cancer care technology.
Lefkofsky began his entrepreneurial career early. Right after finishing law school in 1993, he and a friend co-bought an apparel company called Brandon Apparel. From there, they launched several successful businesses and in 2007, Lefkofsky co-founded Thepoint.com, which became Groupon.com in late 2008.
Aside from his many business ventures, Eric Lefkofsky and his wife Elizabeth formed the Lefkoksky Foundation. A charitable trust organization, the Lefkofsky Foundation supports causes in relation to education, science, and philanthropy. To date, the foundation has helped fund more than 50 other philanthropic organizations. In 2013, the pair joined The Giving Pledge with a goal of inspiring other wealthy individuals to participate in giving back. Currently, Lefkofsky is an Adjunct Professor at the University of Chicago Booth School of Business, where he teaches aspiring entrepreneurs the steps to success.